These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 26657167)

  • 1. Reply: Parsing the differences in affected with LHON: genetic versus environmental triggers of disease conversion.
    Yu-Wai-Man P; Hudson G; Klopstock T; Chinnery PF
    Brain; 2016 Mar; 139(Pt 3):e18. PubMed ID: 26657167
    [No Abstract]   [Full Text] [Related]  

  • 2. Parsing the differences in affected with LHON: genetic versus environmental triggers of disease conversion.
    Carelli V; d'Adamo P; Valentino ML; La Morgia C; Ross-Cisneros FN; Caporali L; Maresca A; Loguercio Polosa P; Barboni P; De Negri A; Sadun F; Karanjia R; Salomao SR; Berezovsky A; Chicani F; Moraes M; Moraes Filho M; Belfort R; Sadun AA
    Brain; 2016 Mar; 139(Pt 3):e17. PubMed ID: 26657166
    [No Abstract]   [Full Text] [Related]  

  • 3. Dominant Optic Atrophy and Leber's Hereditary Optic Neuropathy: Update on Clinical Features and Current Therapeutic Approaches.
    Chun BY; Rizzo JF
    Semin Pediatr Neurol; 2017 May; 24(2):129-134. PubMed ID: 28941528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitochondrial optic neuropathies - disease mechanisms and therapeutic strategies.
    Yu-Wai-Man P; Griffiths PG; Chinnery PF
    Prog Retin Eye Res; 2011 Mar; 30(2):81-114. PubMed ID: 21112411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Review of Mitochondrial Optic Neuropathies: From Inherited to Acquired Forms.
    Pilz YL; Bass SJ; Sherman J
    J Optom; 2017; 10(4):205-214. PubMed ID: 28040497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of hereditary optic neuropathies.
    Newman NJ
    Nat Rev Neurol; 2012 Oct; 8(10):545-56. PubMed ID: 22945544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic Approaches to Inherited Optic Neuropathies.
    Yu-Wai-Man P
    Semin Neurol; 2015 Oct; 35(5):578-86. PubMed ID: 26444403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emerging Mitochondrial Therapeutic Targets in Optic Neuropathies.
    Lopez Sanchez MI; Crowston JG; Mackey DA; Trounce IA
    Pharmacol Ther; 2016 Sep; 165():132-52. PubMed ID: 27288727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment strategies for inherited optic neuropathies: past, present and future.
    Yu-Wai-Man P; Votruba M; Moore AT; Chinnery PF
    Eye (Lond); 2014 May; 28(5):521-37. PubMed ID: 24603424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mitochondrial dysfunction in optic neuropathies: animal models and therapeutic options.
    Carelli V; La Morgia C; Sadun AA
    Curr Opin Neurol; 2013 Feb; 26(1):52-8. PubMed ID: 23302804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hereditary optic neuropathies: from the mitochondria to the optic nerve.
    Newman NJ
    Am J Ophthalmol; 2005 Sep; 140(3):517-23. PubMed ID: 16083845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Melanopsin retinal ganglion cells are resistant to neurodegeneration in mitochondrial optic neuropathies.
    La Morgia C; Ross-Cisneros FN; Sadun AA; Hannibal J; Munarini A; Mantovani V; Barboni P; Cantalupo G; Tozer KR; Sancisi E; Salomao SR; Moraes MN; Moraes-Filho MN; Heegaard S; Milea D; Kjer P; Montagna P; Carelli V
    Brain; 2010 Aug; 133(Pt 8):2426-38. PubMed ID: 20659957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leber Hereditary Optic Neuropathy: Bringing the Lab to the Clinic.
    Rasool N; Lessell S; Cestari DM
    Semin Ophthalmol; 2016; 31(1-2):107-16. PubMed ID: 26959136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hereditary optic neuropathies share a common mitochondrial coupling defect.
    Chevrollier A; Guillet V; Loiseau D; Gueguen N; de Crescenzo MA; Verny C; Ferre M; Dollfus H; Odent S; Milea D; Goizet C; Amati-Bonneau P; Procaccio V; Bonneau D; Reynier P
    Ann Neurol; 2008 Jun; 63(6):794-8. PubMed ID: 18496845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hereditary optic neuropathies.
    Newman NJ; Biousse V
    Eye (Lond); 2004 Nov; 18(11):1144-60. PubMed ID: 15534600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Poison and antidote: a novel model to study pathogenesis and therapy of LHON.
    Manfredi G; Beal MF
    Ann Neurol; 2004 Aug; 56(2):171-2. PubMed ID: 15293268
    [No Abstract]   [Full Text] [Related]  

  • 17. [How to distinguish between autosomal dominant optic atrophy and Leber's hereditary optic neuropathy].
    Leo-Kottler B; Jägle H; Küpker T; Schimpf S
    Ophthalmologe; 2007 Dec; 104(12):1060-5. PubMed ID: 17899121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leber hereditary optic neuropathy.
    Yu-Wai-Man P; Turnbull DM; Chinnery PF
    J Med Genet; 2002 Mar; 39(3):162-9. PubMed ID: 11897814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical and molecular genetic analysis of hereditary optic neuropathies].
    Avetisov SÉ; Sheremet NL; Vorob'eva OK; Eliseeva ÉG; Chukhrova AL; Loginova AN; Khanakova NA; Poliakov AV
    Vestn Oftalmol; 2013; 129(2):8-13. PubMed ID: 23808173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diffusion Tensor Imaging Mapping of Brain White Matter Pathology in Mitochondrial Optic Neuropathies.
    Manners DN; Rizzo G; La Morgia C; Tonon C; Testa C; Barboni P; Malucelli E; Valentino ML; Caporali L; Strobbe D; Carelli V; Lodi R
    AJNR Am J Neuroradiol; 2015 Jul; 36(7):1259-65. PubMed ID: 25792533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.